Asthma Meds Too Expensive for World's Poor

Although 300 million people suffer from asthma globally, with 250,000 estimated deaths, for many living in low- and middle-income countries, access to quality-assured, affordable asthma-essential medicines still remains a distant dream according to a study published in the journal PharmacoEcoomics.

Read →

Comments on this post are for paid subscribers